Jones; S. Tarran

Patent Applications and Registrations

Patent applications and USPTO patent grants for Jones; S. Tarran.The latest application filed is for "humanized anti-ccr2 antibodies and methods of use therefor".

Company Profile

0.12.13

Jones; S. Tarran - Radlett N/A GB
Jones; S. Tarran - Hertfordshire GB

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Humanized anti-CCR2 antibodies and methods of use therefor Grant 8,926,971 - LaRosa , et al. January 6, 2	2015-01-06
Humanized Anti-ccr2 Antibodies And Methods Of Use Therefor App 20130071381 - LaRosa; Gregory J. ; et al.	2013-03-21
Humanized anti-CCR2 antibodies and methods of use therefor Grant 8,227,211 - LaRosa , et al. July 24, 2	2012-07-24
Humanized Anti-ccr2 Antibodies And Methods Of Use Therefor App 20090191192 - LaRosa; Gregory J. ; et al.	2009-07-30
Humanized anti-CCR2 antibodies and methods of use therefor Grant 7,566,450 - LaRosa , et al. July 28, 2	2009-07-28
Humanized Anti-CCR2 Antibodies and Methods of Use Therefor App 20090169541 - LaRosa; Gregory J. ; et al.	2009-07-02
Humanized Anti-CCR2 Antibodies and Methods of Use Therefor App 20090142339 - LaRosa; Gregory J. ; et al.	2009-06-04
Humanized immunoglubulin reactive with alph4beta7 integrin App 20090011464 - Ponath; Paul D. ; et al.	2009-01-08
Humanized anti-CCR2 antibodies and methods of use therefor Grant 7,473,421 - LaRosa , et al. January 6, 2	2009-01-06
Humanized Anti-CCR2 Antibodies and Methods of Use Therefor App 20080268536 - LaRosa; Gregory J. ; et al.	2008-10-30
Humanized anti-CCR2 antibodies and methods of use therefor Grant 7,442,775 - LaRosa , et al. October 28, 2	2008-10-28
Humanized Anti-CCR2 Antibodies and Methods of Use Therefor App 20080241923 - LaRosa; Gregory J. ; et al.	2008-10-02
Humanized Anti-CCR2 Antibodies and Methods of Use Therefor App 20080241136 - LaRosa; Gregory J. ; et al.	2008-10-02
Humanized immunoglobulin reactive with .alpha.4.beta.7 integrin Grant 7,402,410 - Ponath , et al. July 22, 2	2008-07-22
Humanized immunoglobulin reactive with alpha4beta7 integrin App 20060292140 - Ponath; Paul D. ; et al.	2006-12-28
Humanized immunoglobulin reactive with .alpha.4.beta.7 integrin Grant 7,147,851 - Ponath , et al. December 12, 2	2006-12-12
Humanized anti-CCR2 antibodies and methods of use therefor App 20040132980 - LaRosa, Gregory J. ; et al.	2004-07-08
Humanized anti-CCR2 antibodies and methods of use therefor App 20040126851 - LaRosa, Gregory J. ; et al.	2004-07-01
Recombinant anti-CCR2 antibodies and methods of use therefor Grant 6,727,349 - LaRosa , et al. April 27, 2	2004-04-27
Humanized anti-CCR2 antibodies and methods of use therefor Grant 6,696,550 - LaRosa , et al. February 24, 2	2004-02-24
Humanized anti-CCR2 antibodies and methods of use therefor App 20020150576 - LaRosa, Gregory J. ; et al.	2002-10-17
Humanized antibodies against leukocyte adhesion molecule VLA-4 Grant 5,840,299 - Bendig , et al. November 24, 1	1998-11-24
Antibodies to P-selectin and their uses Grant 5,800,815 - Chestnut , et al. September 1, 1	1998-09-01

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.